|
US5800815A
(en)
|
1903-05-05 |
1998-09-01 |
Cytel Corporation |
Antibodies to P-selectin and their uses
|
|
US4450103A
(en)
|
1982-03-01 |
1984-05-22 |
Cetus Corporation |
Process for recovering human IFN-β from a transformed microorganism
|
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4959314A
(en)
|
1984-11-09 |
1990-09-25 |
Cetus Corporation |
Cysteine-depleted muteins of biologically active proteins
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
WO1989012624A2
(en)
|
1988-06-14 |
1989-12-28 |
Cetus Corporation |
Coupling agents and sterically hindered disulfide linked conjugates prepared therefrom
|
|
EP0353450B1
(en)
|
1988-06-24 |
1995-03-29 |
The Dow Chemical Company |
Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
|
|
US5753627A
(en)
|
1988-12-05 |
1998-05-19 |
Novartis Ag |
Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5705363A
(en)
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
|
ATE120374T1
(de)
|
1989-07-20 |
1995-04-15 |
Sandoz Ag |
Markierte polypeptidderivate.
|
|
US5730978A
(en)
|
1989-09-01 |
1998-03-24 |
Fred Hutchinson Cancer Research Center |
Inhibition of lymphocyte adherence with α4β1-specific antibodies
|
|
US6033665A
(en)
|
1989-09-27 |
2000-03-07 |
Elan Pharmaceuticals, Inc. |
Compositions and methods for modulating leukocyte adhesion to brain endothelial cells
|
|
US5292658A
(en)
|
1989-12-29 |
1994-03-08 |
University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center |
Cloning and expressions of Renilla luciferase
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
IL99552A0
(en)
|
1990-09-28 |
1992-08-18 |
Ixsys Inc |
Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
|
|
CA2103553A1
(en)
|
1991-12-10 |
1993-06-11 |
Garry E. Kiefer |
Bicyclopolyazamacrocyclocarboxylic acid complexes their conjugates, processes for their preparation, and use as radiopharmaceuticals
|
|
CA2127462C
(en)
|
1992-01-13 |
1999-03-23 |
Roy R. Lobb |
Treatment for asthma
|
|
JPH07506566A
(ja)
|
1992-02-12 |
1995-07-20 |
バイオゲン インコーポレイテッド |
炎症性胃腸病の処置
|
|
EP0677060A1
(en)
|
1993-01-08 |
1995-10-18 |
Tanabe Seiyaku Co., Ltd. |
Peptide inhibitors of cell adhesion
|
|
SG44845A1
(en)
|
1993-01-12 |
1997-12-19 |
Biogen Inc |
Recombitant anti-vla4 antibody molecules
|
|
US5928904A
(en)
|
1993-09-07 |
1999-07-27 |
Smithkline Beecham Corporation |
DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
|
|
US5914110A
(en)
|
1993-09-07 |
1999-06-22 |
Smithkline Beecham Corporation |
Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
|
|
US5821231A
(en)
|
1993-12-06 |
1998-10-13 |
Cytel Corporation |
CS-1 peptidomimetics, compositions and methods of using same
|
|
AU693143B2
(en)
|
1993-12-06 |
1998-06-25 |
Cytel Corporation |
CS-1 peptidomimetics, compositions and methods of using the same
|
|
US5936065A
(en)
|
1993-12-06 |
1999-08-10 |
Cytel Corporation |
CS-1 peptidomimetics, compositions and methods of using the same
|
|
US5840299A
(en)
|
1994-01-25 |
1998-11-24 |
Athena Neurosciences, Inc. |
Humanized antibodies against leukocyte adhesion molecule VLA-4
|
|
DE69535133T2
(de)
|
1994-01-25 |
2008-08-21 |
Elan Pharmaceuticals, Inc., San Francisco |
Humanisierte antikörper gegen das leukozytenadhäsionsmolekül vla-4
|
|
US8715645B2
(en)
|
1994-05-27 |
2014-05-06 |
The Regents Of The University Of Colorado |
Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
AU2958195A
(en)
|
1994-06-29 |
1996-01-25 |
Texas Biotechnology Corporation |
Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
|
|
US5811391A
(en)
|
1994-08-25 |
1998-09-22 |
Cytel Corporation |
Cyclic CS-1 peptidomimetics, compositions and methods of using same
|
|
US5874540A
(en)
|
1994-10-05 |
1999-02-23 |
Immunomedics, Inc. |
CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
|
|
US5674842A
(en)
|
1994-10-26 |
1997-10-07 |
Health Research, Incorporated |
Growth inhibitory peptide
|
|
US5670356A
(en)
|
1994-12-12 |
1997-09-23 |
Promega Corporation |
Modified luciferase
|
|
US6306840B1
(en)
|
1995-01-23 |
2001-10-23 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
WO1996040781A1
(en)
|
1995-06-07 |
1996-12-19 |
Tanabe Seiyaku Co., Ltd. |
CYCLIC PEPTIDE INHIBITORS OF β1 AND β2 INTEGRIN-MEDIATED ADHESION
|
|
WO1997000271A1
(en)
*
|
1995-06-14 |
1997-01-03 |
The Regents Of The University Of California |
Novel high affinity human antibodies to tumor antigens
|
|
JPH11508583A
(ja)
|
1995-07-06 |
1999-07-27 |
ゼネカ・リミテッド |
ペプチド系のフィブロネクチン阻害薬
|
|
US6248713B1
(en)
|
1995-07-11 |
2001-06-19 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
GB9613112D0
(en)
|
1996-06-21 |
1996-08-28 |
Zeneca Ltd |
Chemical compounds
|
|
JP2000516596A
(ja)
|
1996-07-25 |
2000-12-12 |
バイオジェン,インコーポレイテッド |
細胞接着インヒビター
|
|
US6686350B1
(en)
|
1996-07-25 |
2004-02-03 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
DE19647380A1
(de)
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
DE19647382A1
(de)
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
DE19647381A1
(de)
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
WO1998042656A1
(en)
|
1997-03-21 |
1998-10-01 |
Cytel Corporation |
Novel compounds
|
|
ATE318841T1
(de)
|
1997-05-29 |
2006-03-15 |
Merck & Co Inc |
Biarylalkansäuren in der verwendung als zelladhäsionsinhibitoren
|
|
EP1001764A4
(en)
|
1997-05-29 |
2005-08-24 |
Merck & Co Inc |
HETEROCYCLIC AMIDE COMPOUNDS AS INHIBITORS OF CELL ADHESION
|
|
CA2291708A1
(en)
|
1997-05-29 |
1998-12-03 |
Merck & Co., Inc. |
Sulfonamides as cell adhesion inhibitors
|
|
US6191269B1
(en)
|
1997-05-30 |
2001-02-20 |
The Regents Of The University Of California |
Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
|
|
WO1998054207A1
(en)
|
1997-05-30 |
1998-12-03 |
Celltech Therapeutics Limited |
Anti-inflammatory tyrosine derivatives
|
|
ATE249421T1
(de)
|
1997-06-23 |
2003-09-15 |
Tanabe Seiyaku Co |
Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
|
|
CN1265675A
(zh)
|
1997-07-31 |
2000-09-06 |
伊兰药品公司 |
抑制由vla-4介导的白细胞粘着的苄基化合物
|
|
AU8661298A
(en)
|
1997-07-31 |
1999-02-22 |
American Home Products Corporation |
Dipeptide compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
AR016133A1
(es)
|
1997-07-31 |
2001-06-20 |
Wyeth Corp |
Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria
|
|
BR9811594A
(pt)
|
1997-07-31 |
2000-09-05 |
Elan Pharm Inc |
Compostos de dipeptìdeo sulfonilados que inibem adesão de leucócito mediada por vla-4
|
|
IL133640A0
(en)
|
1997-07-31 |
2001-04-30 |
Elan Pharm Inc |
Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
IL133641A0
(en)
|
1997-07-31 |
2001-04-30 |
Elan Pharm Inc |
Compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
PL338373A1
(en)
|
1997-07-31 |
2000-10-23 |
Elan Pharm Inc |
Dipeptide and its affinite compounds inhibiting adhesion of leucocytes occurring through mediation of vla-4
|
|
KR20010022414A
(ko)
|
1997-07-31 |
2001-03-15 |
진 엠. 듀발 |
Vla-4에 의해 매개되는 백혈구 부착을 억제시키는4-아미노-페닐알라닌형 화합물
|
|
US6229011B1
(en)
|
1997-08-22 |
2001-05-08 |
Hoffman-La Roche Inc. |
N-aroylphenylalanine derivative VCAM-1 inhibitors
|
|
KR100554815B1
(ko)
|
1997-08-22 |
2006-02-22 |
에프. 호프만-라 로슈 아게 |
엔-아로일페닐알라닌 유도체
|
|
ATE260243T1
(de)
|
1997-08-22 |
2004-03-15 |
Hoffmann La Roche |
N-aroylphenylalaninderivate
|
|
US6455550B1
(en)
|
1997-08-22 |
2002-09-24 |
Hoffmann-La Roche Inc. |
N-alkanoylphenylalanine derivatives
|
|
DE19741235A1
(de)
|
1997-09-18 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
AU1361499A
(en)
|
1997-10-21 |
1999-05-10 |
Merck & Co., Inc. |
Azapeptide acids as cell adhesion inhibitors
|
|
DK1027328T3
(da)
|
1997-10-31 |
2006-11-13 |
Aventis Pharma Ltd |
Substituerede anilider
|
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
|
AU1415099A
(en)
|
1997-11-18 |
1999-06-07 |
Merck & Co., Inc. |
4-substituted-4-piperidine carboxamide derivatives
|
|
DE19751251A1
(de)
|
1997-11-19 |
1999-05-20 |
Hoechst Marion Roussel De Gmbh |
Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
|
|
WO1999026923A1
(en)
|
1997-11-20 |
1999-06-03 |
Merck & Co., Inc. |
Para-aminomethylaryl carboxamide derivatives
|
|
WO1999026922A1
(en)
|
1997-11-21 |
1999-06-03 |
Merck & Co., Inc. |
Substituted pyrrole derivatives as cell adhesion inhibitors
|
|
ES2221227T3
(es)
|
1997-11-24 |
2004-12-16 |
MERCK & CO., INC. |
Derivados sustituidos de beta-alanina como inhibidores de la adhesion celular.
|
|
JP2001523711A
(ja)
|
1997-11-24 |
2001-11-27 |
メルク エンド カムパニー インコーポレーテッド |
細胞接着阻害薬としての環状アミノ酸誘導体
|
|
US6197794B1
(en)
|
1998-01-08 |
2001-03-06 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
MY153569A
(en)
|
1998-01-20 |
2015-02-27 |
Mitsubishi Tanabe Pharma Corp |
Inhibitors of ?4 mediated cell adhesion
|
|
CN1294576A
(zh)
|
1998-01-23 |
2001-05-09 |
诺瓦提斯公司 |
Vla-4拮抗剂
|
|
US6329372B1
(en)
|
1998-01-27 |
2001-12-11 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
US6171809B1
(en)
|
1998-01-29 |
2001-01-09 |
Packard Instrument Company |
Method and compositions for detecting luciferase biological samples
|
|
JP2002504534A
(ja)
|
1998-02-26 |
2002-02-12 |
セルテック・セラピューティクス・リミテッド |
α4インテグリンの阻害剤としてのフェニルアラニン誘導体
|
|
SK14812000A3
(sk)
|
1998-04-03 |
2001-08-06 |
Chugai Seiyaku Kabushiki Kaisha |
Chimérny reťazec protilátky, chimérna protilátka, v oblasť, humanizovaný reťazec protilátky, humanizovaná protilátka, dna, expresný vektor, hostiteľ, spôsob prípravy a liečivo
|
|
GB9811159D0
(en)
|
1998-05-22 |
1998-07-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
DK1082302T3
(da)
|
1998-05-28 |
2004-04-26 |
Biogen Inc |
En VLA-4-inhibitor: oMePUPA-V
|
|
GB9812088D0
(en)
|
1998-06-05 |
1998-08-05 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6685617B1
(en)
|
1998-06-23 |
2004-02-03 |
Pharmacia & Upjohn Company |
Inhibitors of α4β1 mediated cell adhesion
|
|
US6355678B1
(en)
*
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
|
GB9821061D0
(en)
|
1998-09-28 |
1998-11-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
DK1656952T3
(da)
|
1998-10-16 |
2014-01-20 |
Biogen Idec Inc |
Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf
|
|
JP3180906B2
(ja)
|
1998-11-12 |
2001-07-03 |
日本電気株式会社 |
磁気抵抗効果型複合ヘッドの製造方法
|
|
CA2362831C
(en)
|
1999-02-18 |
2008-10-07 |
F. Hoffmann-La Roche Ag |
Thioamide derivatives
|
|
US6265572B1
(en)
|
1999-04-20 |
2001-07-24 |
Hoffmann-La Roche Inc. |
Pyrrolidincarbonylamino cyclic disulfide anti-inflammatory agents
|
|
US6756378B2
(en)
|
1999-06-30 |
2004-06-29 |
Pharmacopeia Drug Discovery, Inc. |
VLA-4 inhibitor compounds
|
|
US7067313B1
(en)
|
1999-07-14 |
2006-06-27 |
D. Collen Research Foundation |
Ligands for use in therapeutic compositions for the treatment of hemostasis disorders
|
|
US6365619B1
(en)
|
1999-07-22 |
2002-04-02 |
Novartis Ag |
Treatment of arteriosclerosis
|
|
ES2270868T3
(es)
|
1999-08-13 |
2007-04-16 |
Biogen Idec Ma Inc. |
Inhibidores de la adhesion celular.
|
|
US6531122B1
(en)
|
1999-08-27 |
2003-03-11 |
Maxygen Aps |
Interferon-β variants and conjugates
|
|
CA2383784A1
(en)
|
1999-09-02 |
2001-03-08 |
Leadd B.V. |
Apoptin-associating protein
|
|
EP1094110A1
(en)
|
1999-10-21 |
2001-04-25 |
Leadd B.V. |
Apoptosis inducing proteinaceous substance
|
|
WO2001036376A1
(en)
|
1999-11-18 |
2001-05-25 |
Ajinomoto Co., Inc. |
Novel phenylalanine derivatives
|
|
DK1244625T3
(da)
|
1999-12-06 |
2005-10-10 |
Hoffmann La Roche |
4-pyridinyl-n-acyl-l-phenylalaniner
|
|
US6388084B1
(en)
|
1999-12-06 |
2002-05-14 |
Hoffmann-La Roche Inc. |
4-pyridinyl-n-acyl-l-phenylalanines
|
|
US6380387B1
(en)
|
1999-12-06 |
2002-04-30 |
Hoffmann-La Roche Inc. |
4-Pyrimidinyl-n-acyl-l phenylalanines
|
|
DE19962936A1
(de)
|
1999-12-24 |
2001-06-28 |
Bayer Ag |
Neue beta-Aminosäureverbindungen als Integrinantagonisten
|
|
EP1243577A4
(en)
|
1999-12-28 |
2005-06-08 |
Ajinomoto Kk |
NEW PHENYLALANINE DERIVATIVES
|
|
YU41202A
(sh)
|
1999-12-28 |
2005-03-15 |
Pfizer Products Inc. |
Ne-peptidni inhibitori vezivanja za ćeliju zavisnog od vla-4 korisni pri tretiranju inflamatornih, autoimunih i respiratornih bolesti
|
|
US7446174B2
(en)
|
2001-03-02 |
2008-11-04 |
Xencor, Inc. |
Protein based TNF-α variants for the treatment of TNF-α related disorders
|
|
WO2001070670A1
(en)
|
2000-03-23 |
2001-09-27 |
Ajinomoto Co., Inc. |
Novel phenylalanine derivative
|
|
EP1289552B1
(en)
|
2000-05-19 |
2006-03-29 |
The Center for Blood Research, INC. |
Methods for treating hemostatic disorders by soluble p-selectin
|
|
GB0027328D0
(en)
*
|
2000-06-23 |
2000-12-27 |
Aventis Pharma Inc |
Bioengineered vehicles for targeted nucleic acid delivery
|
|
US20040247565A1
(en)
|
2000-07-19 |
2004-12-09 |
Chih-Ping Liu |
Method of treatment using interferon-tau
|
|
US7015216B2
(en)
|
2000-07-21 |
2006-03-21 |
Elan Pharmaceuticals, Inc. |
Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors
|
|
AU2001278986A1
(en)
|
2000-07-21 |
2002-02-05 |
Elan Pharmaceuticals, Inc. |
3-amino-2-(4-aminocarbonyloxy)phenyl-propionic acid derivatives as alpha-4- integrin inhibitors
|
|
CA2420040C
(en)
|
2000-08-18 |
2009-02-03 |
Ajinomoto Co., Inc. |
New phenylalanine derivatives
|
|
WO2002022563A1
(en)
|
2000-09-14 |
2002-03-21 |
Toray Industries, Inc. |
Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
|
|
AU8811401A
(en)
|
2000-09-25 |
2002-04-02 |
Toray Industries |
Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
|
|
JP4895067B2
(ja)
|
2000-09-29 |
2012-03-14 |
味の素株式会社 |
新規フェニルアラニン誘導体
|
|
US6818216B2
(en)
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
MXPA03006796A
(es)
|
2001-02-22 |
2004-05-31 |
Celltch R & D Ltd |
Derivados de enamida de fenilalanina que poseen grupo ciclobuteno, para uso como inhibidores de integrina.
|
|
ES2180416B1
(es)
*
|
2001-03-12 |
2004-06-01 |
BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. |
Procedimiento para la preparacion de mezclas de reaccion estabilizadas, total o parcialmente desecadas, que comprenden, al menos, una enzima, mezclas de reaccion y kits que las contienen.
|
|
CA2454048C
(en)
|
2001-07-17 |
2011-05-03 |
Research Development Foundation |
Therapeutic agents comprising pro-apoptotic proteins
|
|
WO2003010135A1
(en)
|
2001-07-26 |
2003-02-06 |
Ajinomoto Co., Inc. |
Novel phenylpropionic acid derivatives
|
|
US6900292B2
(en)
*
|
2001-08-17 |
2005-05-31 |
Lee-Hwei K. Sun |
Fc fusion proteins of human erythropoietin with increased biological activities
|
|
WO2003053926A1
(en)
|
2001-12-13 |
2003-07-03 |
Ajinomoto Co.,Inc. |
Novel phenylalanine derivative
|
|
CA2841097A1
(en)
*
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin and g-csf fusion proteins
|
|
KR101271635B1
(ko)
*
|
2001-12-21 |
2013-06-12 |
휴먼 게놈 사이언시즈, 인코포레이티드 |
알부민 융합 단백질
|
|
US7399829B2
(en)
|
2002-01-04 |
2008-07-15 |
Xencor, Inc. |
Variants of RANKL protein
|
|
WO2003080611A1
(en)
|
2002-03-22 |
2003-10-02 |
Toray Industries, Inc. |
Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
|
|
US7332580B2
(en)
*
|
2002-04-05 |
2008-02-19 |
The Regents Of The University Of California |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
US7332585B2
(en)
*
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
GB0216568D0
(en)
|
2002-07-17 |
2002-08-28 |
Celltech R&D Ltd |
Chemical compounds
|
|
GB0216571D0
(en)
|
2002-07-17 |
2002-08-28 |
Celltech R&D Ltd |
Chemical compounds
|
|
US7314613B2
(en)
|
2002-11-18 |
2008-01-01 |
Maxygen, Inc. |
Interferon-alpha polypeptides and conjugates
|
|
US7413874B2
(en)
|
2002-12-09 |
2008-08-19 |
University Of Miami |
Nucleic acid encoding fluorescent proteins from aquatic species
|
|
US20040115204A1
(en)
|
2002-12-11 |
2004-06-17 |
Fanger Gary R. |
Antibodies to treat cancer
|
|
WO2004078112A2
(en)
|
2003-03-07 |
2004-09-16 |
Asahi Kasei Pharma Corporation |
Apoptosis inducing gene
|
|
US7446125B2
(en)
|
2003-04-09 |
2008-11-04 |
Universidad Del Pais Vasco |
Derivatives of nitroproline compounds, processes of manufacture and uses in the treatment of integrin mediated disorders
|
|
GB0308511D0
(en)
|
2003-04-14 |
2003-05-21 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
WO2005035719A2
(en)
|
2003-10-03 |
2005-04-21 |
Board Of Control Of Michigan Technological University |
Modified luciferase
|
|
US7638331B2
(en)
|
2004-01-02 |
2009-12-29 |
The Administration of the Tulane Rducation Fund |
Directed apoptosis in COX-2 overexpressing cancer cells through expression targeted gene delivery
|
|
WO2005100402A1
(en)
|
2004-04-13 |
2005-10-27 |
F.Hoffmann-La Roche Ag |
Anti-p-selectin antibodies
|
|
AU2005249396B2
(en)
|
2004-05-05 |
2011-10-20 |
Merrimack Pharmaceuticals, Inc. |
Bispecific binding agents for modulating biological activity
|
|
TW200610754A
(en)
|
2004-06-14 |
2006-04-01 |
Daiichi Seiyaku Co |
Vla-4 inhibitor
|
|
US7196112B2
(en)
|
2004-07-16 |
2007-03-27 |
Biogen Idec Ma Inc. |
Cell adhesion inhibitors
|
|
CN101048427B
(zh)
|
2004-07-23 |
2015-01-14 |
健泰科生物技术公司 |
抗体或其片段的结晶
|
|
CN101163501A
(zh)
|
2005-02-23 |
2008-04-16 |
梅里麦克制药股份有限公司 |
调节生物活性的双特异性结合剂
|
|
CA2607651A1
(en)
|
2005-05-18 |
2007-04-19 |
Maxygen, Inc. |
Evolved interferon-alpha polypeptides
|
|
US8334258B2
(en)
|
2005-07-26 |
2012-12-18 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts (Universitätsmedizin) |
Method for induction and enhancement of apoptosis in tumor cells
|
|
EP1954713B1
(en)
|
2005-11-04 |
2012-11-14 |
Evrogen, JSC |
Modified green fluorescent proteins and methods for using same
|
|
US20070243163A1
(en)
|
2006-02-17 |
2007-10-18 |
Chih-Ping Liu |
Respiratory tract delivery of interferon-tau
|
|
EP2474318A1
(en)
*
|
2006-06-07 |
2012-07-11 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
WO2008033413A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
JP5639039B2
(ja)
|
2008-04-11 |
2014-12-10 |
メリマック ファーマシューティカルズ インコーポレーティッド |
ヒト血清アルブミンリンカーおよびそのコンジュゲート
|